| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2006-06-026500 |
| P698 | PubMed publication ID | 16960149 |
| P50 | author | Andreas Rosenwald | Q28379725 |
| Felipe Prosper | Q37835050 | ||
| Kei-Ji Sugimoto | Q40234417 | ||
| Jose A Martinez-Climent | Q40234454 | ||
| Xabier Agirre | Q40931651 | ||
| Reiner Siebert | Q78771973 | ||
| P2093 | author name string | Louis M Staudt | |
| Martin J S Dyer | |||
| Juan F García | |||
| Lydia Sanchez | |||
| Daniel Pinkel | |||
| Joan Climent | |||
| Vicente Fresquet | |||
| Miguel Marín | |||
| E Loraine Karran | |||
| Fanny Rubio-Moscardo | |||
| Elena Beltran | |||
| Cinta Mestre-Escorihuela | |||
| Isabel Marugan | |||
| Jose A Richter | |||
| Luise M Wheat | |||
| P2860 | cites work | ArgBP2gamma interacts with Akt and p21-activated kinase-1 and promotes cell survival | Q28241283 |
| Assembly of microarrays for genome-wide measurement of DNA copy number | Q34099918 | ||
| P4510 | describes a project that uses | JeKo-1 | Q54898569 |
| JVM-2 | Q54899192 | ||
| Karpas-1106P | Q54899481 | ||
| Karpas-1718 | Q54899486 | ||
| Karpas-231 | Q54899491 | ||
| Karpas-353 | Q54899497 | ||
| Karpas-422 | Q54899500 | ||
| KHM-10B | Q54899884 | ||
| MD901 | Q54904546 | ||
| MD903 | Q54904547 | ||
| MedB-1 | Q54905007 | ||
| NAB-2 | Q54907363 | ||
| BALM-9 | Q54753219 | ||
| BEVA | Q54796108 | ||
| BL-41 | Q54797155 | ||
| CA46 | Q54808297 | ||
| CIPULLO | Q54813371 | ||
| CTB-1 | Q54814731 | ||
| DoHH2 | Q54831350 | ||
| Elijah | Q54832250 | ||
| Granta-380 | Q54871669 | ||
| Granta-452 | Q54871670 | ||
| Granta-519 | Q54871671 | ||
| HBL-2 | Q54881432 | ||
| IRM2 | Q54898249 | ||
| Namalwa | Q54907447 | ||
| NCEB-1 | Q54907697 | ||
| OCI-Ly8 | Q54931778 | ||
| OZ | Q54937186 | ||
| P32/ISH | Q54937247 | ||
| PL-29018 | Q54947482 | ||
| PR1 | Q54948332 | ||
| RC-K8 | Q54949416 | ||
| REC-1 | Q54949572 | ||
| Ri-1 | Q54950442 | ||
| RL | Q54950574 | ||
| ROS-50 | Q54950834 | ||
| Sc-1 | Q54952223 | ||
| Seraphina | Q54952813 | ||
| SP-49 | Q54955386 | ||
| SP-53 | Q54955389 | ||
| SSK41 | Q54955698 | ||
| SU-DHL-6 | Q54970721 | ||
| UPN1 | Q54991714 | ||
| UPN2 | Q54991716 | ||
| VAL | Q54992842 | ||
| Wien 133 | Q54994058 | ||
| Z-138 | Q54995848 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell line | Q21014462 |
| homozygosity | Q114049690 | ||
| P304 | page(s) | 271-280 | |
| P577 | publication date | 2006-09-07 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas | |
| P478 | volume | 109 |
| Q54753219 | BALM-9 |
| Q54796108 | BEVA |
| Q54797155 | BL-41 |
| Q54808297 | CA46 |
| Q54813371 | CIPULLO |
| Q54814731 | CTB-1 |
| Q54831350 | DoHH2 |
| Q54832250 | Elijah |
| Q54871669 | Granta-380 |
| Q54871670 | Granta-452 |
| Q54871671 | Granta-519 |
| Q54881432 | HBL-2 |
| Q54898249 | IRM2 |
| Q54899192 | JVM-2 |
| Q54898569 | JeKo-1 |
| Q54899884 | KHM-10B |
| Q54899481 | Karpas-1106P |
| Q54899486 | Karpas-1718 |
| Q54899491 | Karpas-231 |
| Q54899497 | Karpas-353 |
| Q54899500 | Karpas-422 |
| Q54904546 | MD901 |
| Q54904547 | MD903 |
| Q54905007 | MedB-1 |
| Q54907363 | NAB-2 |
| Q54907697 | NCEB-1 |
| Q54907447 | Namalwa |
| Q54931778 | OCI-Ly8 |
| Q54937186 | OZ |
| Q54937247 | P32/ISH |
| Q54947482 | PL-29018 |
| Q54948332 | PR1 |
| Q54949416 | RC-K8 |
| Q54949572 | REC-1 |
| Q54950574 | RL |
| Q54950834 | ROS-50 |
| Q54950442 | Ri-1 |
| Q54955386 | SP-49 |
| Q54955389 | SP-53 |
| Q54955698 | SSK41 |
| Q54970721 | SU-DHL-6 |
| Q54952223 | Sc-1 |
| Q54952813 | Seraphina |
| Q54991714 | UPN1 |
| Q54991716 | UPN2 |
| Q54992842 | VAL |
| Q54994058 | Wien 133 |
| Q54995848 | Z-138 |
| Q35134208 | A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma |
| Q39496794 | A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene. |
| Q38061861 | A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia |
| Q35040972 | A single nucleotide polymorphism in cBIM is associated with a slower achievement of major molecular response in chronic myeloid leukaemia treated with imatinib |
| Q30466831 | A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers. |
| Q34313461 | A tumour suppressor network relying on the polyamine-hypusine axis |
| Q54987213 | Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma. |
| Q89996308 | Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma |
| Q42173208 | Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo. |
| Q54686490 | Amplifications and target genes in diffuse large B-cell lymphoma: real targets or consequences of structural features of the genome? |
| Q36963811 | Apoptosis regulators as targets for cancer therapy |
| Q35088734 | Apoptotic cell signaling in cancer progression and therapy |
| Q27314550 | Arg Kinase-binding Protein 2 (ArgBP2) Interaction with α-Actinin and Actin Stress Fibers Inhibits Cell Migration |
| Q37406767 | ArgBP2 and the SoHo family of adapter proteins in oncogenic diseases |
| Q54647015 | Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim. |
| Q92965138 | BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines |
| Q38779981 | BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. |
| Q37797387 | BH3-Only Proteins and Their Effects on Cancer |
| Q34085370 | BH3-only proteins in apoptosis and beyond: an overview |
| Q35883875 | BH3-only proteins in apoptosis at a glance |
| Q37629756 | BH3-only proteins: the death-puppeteer's wires |
| Q30395557 | Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199. |
| Q37373448 | Bcl2 family proteins in carcinogenesis and the treatment of cancer. |
| Q35737865 | Bim and Bmf in tissue homeostasis and malignant disease |
| Q33760917 | Bryostatin analogue-induced apoptosis in mantle cell lymphoma cell lines |
| Q36498110 | C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia. |
| Q33674213 | Cellular stress responses: cell survival and cell death |
| Q57261264 | Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia |
| Q42111039 | Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK. |
| Q39370931 | Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia |
| Q36812163 | Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. |
| Q37723472 | Deregulated cell death and lymphocyte homeostasis cause premature lethality in mice lacking the BH3-only proteins Bim and Bmf. |
| Q36943634 | Detection of DNA copy number alterations in cancer by array comparative genomic hybridization |
| Q33762936 | Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies |
| Q52655175 | Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis. |
| Q39574931 | Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma |
| Q47690517 | Dynein light chain 1 induces assembly of large Bim complexes on mitochondria that stabilize Mcl-1 and regulate apoptosis |
| Q35909637 | Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies |
| Q39149974 | Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma |
| Q28307506 | ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells |
| Q38398064 | Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment. |
| Q34357441 | Epigenetic silencing of Bim transcription by Spi-1/PU.1 promotes apoptosis resistance in leukaemia |
| Q36801093 | Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. |
| Q64999568 | Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL. |
| Q33654192 | Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities |
| Q34975323 | Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha |
| Q59606812 | Functional antagonism between pro-apoptotic BIM and anti-apoptotic BCL-XL in MYC-induced lymphomagenesis |
| Q40087598 | Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). |
| Q37665549 | Gata3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis |
| Q33577390 | Gene bi-targeting by viral and human miRNAs |
| Q36799850 | Gene expression profiling in diffuse large B-cell lymphoma |
| Q39819083 | Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia. |
| Q39190247 | Gene methylation and silencing of SOCS3 in mantle cell lymphoma |
| Q35850206 | Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines |
| Q39753901 | HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis |
| Q39311207 | High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma. |
| Q37563700 | How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma? |
| Q33343257 | Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene |
| Q35151577 | Identification of cis-acting elements and splicing factors involved in the regulation of BIM Pre-mRNA splicing |
| Q24632870 | Identification of human gene products containing Pro-Pro-x-Tyr (PY) motifs that enhance glutathione and endocytotic marker uptake in yeast |
| Q38850384 | Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts. |
| Q34280884 | In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute |
| Q36970689 | In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas |
| Q37968311 | Insights into the PX (phox-homology) domain and SNX (sorting nexin) protein families: structures, functions and roles in disease |
| Q33945848 | Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma |
| Q35789394 | Integrative genomics analysis of genes with biallelic loss and its relation to the expression of mRNA and micro-RNA in esophageal squamous cell carcinoma |
| Q30179387 | LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth |
| Q49725736 | LITAF is a potential tumor suppressor in pancreatic cancer |
| Q33950857 | LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas. |
| Q35136624 | Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer. |
| Q37564773 | Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells |
| Q34568868 | Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era |
| Q44679554 | Mantle cell lymphoma: taking therapeutic advantage of new insights into the biology |
| Q42675856 | MicroRNA-21 regulates the viability and apoptosis of diffuse large B-cell lymphoma cells by upregulating B cell lymphoma-2. |
| Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
| Q37152738 | Molecular genetic characterization reveals new subsets of mantle cell lymphoma |
| Q38813053 | Molecular mechanisms for tumor resistance to chemotherapy |
| Q35227491 | Mutations associated with Charcot-Marie-Tooth disease cause SIMPLE protein mislocalization and degradation by the proteasome and aggresome-autophagy pathways |
| Q36905874 | Negative regulation of Bmi-1 by AMPK and implication in cancer progression |
| Q38866647 | Noxa and cancer therapy: Tuning up the mitochondrial death machinery in response to chemotherapy |
| Q39993811 | Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways |
| Q34707321 | Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors |
| Q37566236 | Noxa: at the tip of the balance between life and death. |
| Q30009491 | Oligomerization and phosphorylation dependent regulation of ArgBP2 adaptive capabilities and associated functions |
| Q45903443 | Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides. |
| Q36782601 | PIG7 promotes leukemia cell chemosensitivity via lysosomal membrane permeabilization |
| Q38332709 | PIG7, transactivated by AML1, promotes apoptosis and differentiation of leukemia cells with AML1–ETO fusion gene |
| Q34074921 | Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling |
| Q46988837 | Patterns of spectrin expression in B-cell lymphomas: loss of spectrin isoforms is associated with nodule-forming and germinal center-related lymphomas |
| Q91474390 | Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma |
| Q38327984 | Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia. |
| Q34891746 | Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds |
| Q92698655 | Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma |
| Q34167987 | Prognostic impact of bim, puma, and noxa expression in human colon carcinomas. |
| Q41860419 | Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis |
| Q37272067 | RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice. |
| Q30456436 | Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop |
| Q26781203 | Regulation of Bim in Health and Disease |
| Q38676677 | Regulation of hematopoietic stem cell integrity through p53 and its related factors. |
| Q38807612 | Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma |
| Q36849731 | SIMPLE: A new regulator of endosomal trafficking and signaling in health and disease |
| Q92727239 | SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway |
| Q37797484 | SOX11 expression in mantle cell lymphoma |
| Q37406791 | SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. |
| Q53485414 | STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma |
| Q35737785 | Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad. |
| Q38996888 | Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies |
| Q37488736 | Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53 |
| Q37634558 | Targeting the BCL-2 family in malignancies of germinal centre origin. |
| Q39575518 | Targeting the Regulatory Machinery of BIM for Cancer Therapy |
| Q38193997 | Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies? |
| Q39177637 | The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells |
| Q24620437 | The Bcl-2 apoptotic switch in cancer development and therapy |
| Q33883661 | The LSD1-interacting protein GILP is a LITAF domain protein that negatively regulates hypersensitive cell death in Arabidopsis |
| Q35180339 | The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment |
| Q28487756 | The Sensitivity of Diffuse Large B-Cell Lymphoma Cell Lines to Histone Deacetylase Inhibitor-Induced Apoptosis Is Modulated by BCL-2 Family Protein Activity |
| Q37325443 | The curious case of the tumour virus: 50 years of Burkitt's lymphoma |
| Q28115594 | The deubiquitinase Usp27x stabilizes the BH3-only protein Bim and enhances apoptosis |
| Q35083049 | The essential role of evasion from cell death in cancer |
| Q39266157 | The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma |
| Q48120159 | The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim. |
| Q45401541 | Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. |
| Q37143660 | Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. |
| Q28306984 | betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis |
| Q38780780 | miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis |
Search more.